The ILC Think Tank, attended by 46 participants including 12 BCRF-funded investigators and held adjacent to the NYC BCRF meeting in October 2025, was considered highly successful, with its discussion-focused format fostering transparent and constructive dialogue on a number of critical topics including potential clinical trial targets and pathways. Three key proposals emerged from the meeting: forming a US-based ILC research working group, establishing an international ILC Association to strengthen collaboration with pharmaceutical partners, and identifying one or two urgent but achievable unmet needs that all attendees, or smaller subgroups, could address as a collaborative initiative.
Invasive Lobular Breast Cancer (ILC) Think Tank, October 27-28, 2025
